Latest in Diabetes
Reuters Health • The Doctor's Channel Daily Newscast
Add-on dapagliflozin improves diabetes control without weight gain
1:57 |
Aug 12, 2011
|
Diabetes, Endocrinology, Family Medicine, Internal Medicine, Pharmacists, Resource Center: Type 2 Diabetes, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – A novel glucose-lowering drug, dapagliflozin, improves glycemic control in patients with type 2 diabetes already on metformin, and it promotes significant weight loss, according to the results of a trial reported in Diabetes Care online August 4.
“Dapagliflozin is a...
Reuters Health • The Doctor's Channel Daily Newscast
Mixed results seen with alpha-lipoic acid for diabetic polyneuropathy
1:37 |
Jul 27, 2011
|
Diabetes, Endocrinology, Neurology & Neurosurgery, Pain Management, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – A 4-year placebo-controlled trial of alpha-lipoic acid to treat diabetes-related polyneuropathy produced no improvement in the study’s composite endpoint, but there were clinically meaningful improvements in impairment due to neuropathy.
Those findings are reported in Diabetes...
Reuters Health • The Doctor's Channel Daily Newscast
Metformin improves outcomes in diabetics with hepatitis C cirrhosis
1:26 |
Jul 22, 2011
|
Diabetes, Endocrinology, Gastroenterology, Infectious Diseases, Resource Center: Type 2 Diabetes, Reuters Health • The Doctor's Channel Daily Newscast
NEW YORK (Reuters Health) – Patients with type 2 diabetes who also have liver cirrhosis associated with hepatitis C virus (HCV) infection fare significantly better when they’re treated with metformin, results of a French study indicate.
“We found that metformin treatment was independently associated...
Weight-based insulin dosing safe at recommended doses
1:15
|
Jul 21, 2011
MI risk high in depressed patients with diabetes
1:15
|
Jul 6, 2011
Retinal video recording a novel option for diabetic retinopathy screening
1:44
|
Jul 1, 2011
ADA Scientific Sessions Day 1 Overview
1:10
|
Jun 24, 2011
Diacerein may improve glycemic control of type 2 diabetes
1:24
|
Jun 3, 2011
Growth hormone treatment does not increase diabetes risk
1:49
|
Jun 1, 2011
Diabetes incidence lower during rosiglitazone treatment
1:32
|
May 31, 2011
Three-year screening interval for diabetic retinopathy appears safe
1:28
|
May 26, 2011
Declining coronary heart disease risk among diabetics
1:42
|
May 24, 2011
Third add-on meds for type 2 diabetes similar in efficacy
1:34
|
May 18, 2011
Another anti-VEGF drug showing promise for diabetic macular edema
1:44
|
May 16, 2011
A1C not reliable for diabetes screening in pediatric population
1:53
|
May 4, 2011
Metformin still best first-line oral hypoglycemic drug for type 2 diabetes
2:30
|
Mar 15, 2011
Both amitriptyline and duloxetine ease diabetic neuropathy
2:05
|
Mar 9, 2011
Less hypoglycemia in type 1 diabetics using continuous glucose monitoring
1:35
|
Mar 4, 2011
Weekly exenatide better than daily for glycemic control in type 2 diabetes
1:52
|
Feb 22, 2011
Serum ketones better than urine ketones for identifying diabetic ketoacidosis
1:24
|
Feb 17, 2011
Tight glycemic control not recommended in hospitalized patients
1:43
|
Feb 14, 2011
Biliopancreatic diversion has lasting benefits on diabetes complications
2:04
|
Feb 10, 2011
Exenatide seen better than insulin for type 2 diabetics
1:51
|
Feb 9, 2011
New ultra-long-acting insulin effective, reduces hypoglycemia
1:54
|
Feb 3, 2011
Contraceptives have minimal effect on glucose and insulin levels
2:03
|
Jan 25, 2011
HbA1C may miss diabetes in adolescents
2:11
|
Jan 25, 2011
Glargine/glulisine insulin regimen preferred for diabetic surgical patients
1:48
|
Jan 21, 2011
Not all insulin analog regimens the same for type 2 diabetes: meta-analysis
1:31
|
Jan 17, 2011
